JPH0253730A - Collection of antitumor substance - Google Patents
Collection of antitumor substanceInfo
- Publication number
- JPH0253730A JPH0253730A JP1099949A JP9994989A JPH0253730A JP H0253730 A JPH0253730 A JP H0253730A JP 1099949 A JP1099949 A JP 1099949A JP 9994989 A JP9994989 A JP 9994989A JP H0253730 A JPH0253730 A JP H0253730A
- Authority
- JP
- Japan
- Prior art keywords
- extracted
- butanol
- extract
- lower alcohol
- antitumor substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 28
- 239000000126 substance Substances 0.000 title claims abstract description 27
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 230000002378 acidificating effect Effects 0.000 claims abstract description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 20
- 239000004922 lacquer Substances 0.000 claims description 12
- 244000025254 Cannabis sativa Species 0.000 claims description 10
- 229910052742 iron Inorganic materials 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000002021 butanolic extract Substances 0.000 claims description 3
- 241001494106 Stenotomus chrysops Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 6
- 239000000243 solution Substances 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 5
- 239000003513 alkali Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 3
- 238000010438 heat treatment Methods 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 241000411851 herbal medicine Species 0.000 description 13
- 239000007787 solid Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 241000209219 Hordeum Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000002246 antineoplastic agent Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002476 tumorcidal effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は生薬、鉄樹葉、蒼耳草、沢漆及び瞿麦からの抗
腫瘍性物質の採取法に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for collecting antitumor substances from crude drugs, iron tree leaves, soybean grass, lacquer lacquer, and soybean grass.
人体に有効な抗腫瘍剤の開発は医療上重要な課題であり
、数多くの物質の抗腫瘍活性が試験されている。これら
の物質は合成物質と天然抽出物質に大別することができ
、天然抽出物質の原料の一つに漢方生薬があげられる。The development of antitumor agents that are effective for the human body is an important medical issue, and the antitumor activity of many substances has been tested. These substances can be broadly classified into synthetic substances and naturally extracted substances, and herbal medicines are one of the raw materials for naturally extracted substances.
漢方生薬はそれぞれ特有の薬理作用を有し、中朽大辞典
(江蘇新医学院編、 1977年、上湯人民出版社)に
は6000種以上の生薬が記されており、抗腫瘍作用が
あると云われているものは100数十種にのぼっている
。そのうち凡そ半数については抗腫瘍活性の本体が解明
されているが、残りは抗腫瘍活性の本体が解明されてい
ない。然しなから、有効成分が不明であるにかかわらず
比較的よい抗癌活性の兆候があると考えられ、他の生薬
と配合され抗癌剤に使用されている漢方生薬が多く存在
する。漢方では単一の生薬のみを使用することは殆んど
なく、数多くの生薬を混合し、その煎剤を使用するので
、混合された生薬の水溶成分の綜合効果として結果が判
定され、混合成分側々の効果は明らかとされていない。Each Chinese herbal medicine has its own unique pharmacological action, and the Middle Ages Dictionary (edited by Jiangsu New Medical Academy, 1977, published by Kamiyu People's Publishing House) lists more than 6,000 kinds of herbal medicines, and they are said to have antitumor effects. There are more than 100 different types. For about half of these, the actual antitumor activity has been elucidated, but for the rest, the actual antitumor activity has not been elucidated. However, even though the active ingredients are unknown, it is thought that there are signs of relatively good anticancer activity, and there are many Chinese herbal medicines that are combined with other herbal medicines and used as anticancer drugs. In Chinese medicine, only a single herbal medicine is rarely used, but a large number of herbal medicines are mixed together and a decoction is used. Therefore, the result is determined as the integrated effect of the water-soluble components of the mixed herbal medicines, and the mixed component side The effects of each are not clear.
従って抗癌剤として配合されている生薬群でどの生薬に
抗腫瘍性物質が含有されているか、効率よく煎剤にそれ
が抽出されているかは不明である。鉄樹葉、蒼耳草、沢
漆及び瞿麦は夫々単一では抗癌、消腫前または情熱利尿
などの効能を有すると考えられており、藤虎湯、参藻湯
、二仙湯。Therefore, it is unclear which of the herbal medicines used as anticancer drugs contain antitumor substances and whether they are efficiently extracted into decoctions. Tetsuju leaf, Somigusa, Sawa lacquer, and Somugi are each thought to have anti-cancer, anti-tumor, and passion diuretic effects when used alone, and are known as Fujikoto, Sanmoto, and Nisento.
両相場などに配合され各種の癌治療に漢方薬として使用
されている。然しなから、これら生薬に抗腫瘍性物質が
含有されているかは不明である。It is used as a Chinese herbal medicine in the treatment of various cancers. However, it is unclear whether these herbal medicines contain antitumor substances.
(発明が解決しようとする課題)
本発明は鉄樹葉2蒼耳草、沢漆及び瞿麦に抗腫瘍性物質
が含有されていることを確かめ、その採取法を提供する
ことを目的としている。(Problems to be Solved by the Invention) The purpose of the present invention is to confirm that the anti-tumor substances are contained in the iron tree leaf 2-sang ear grass, the lacquer lacquer, and the barley, and to provide a method for collecting the same.
(課題を解決するための手段及び作用)鉄樹葉、蒼耳草
、沢漆及び瞿麦によりの抗腫瘍性物質の採取法を検討し
た結果、これら生薬はいずれも強い抗腫瘍性物質を含有
することを認め、鉄樹葉、蒼耳草及び沢漆からは同じ採
取法で抗腫瘍性物質が採取できるが、瞿麦からの抗腫瘍
性物質の採取法は前記3生薬からの採取法では採取され
ないことを知った。鉄樹葉、蒼耳草及び沢漆を酸性低級
アルコールにて抽出し、溶媒を情夫して抽出エキスをえ
る。この抽出エキスを稀アルカリ水溶液に溶解させ、n
−ブタノールを加えて振盪した後ブタノール層を採取し
、ブタノールを情夫して抗腫瘍性物質をえる。この物質
はクロマトグラフィー、その他常法により精製し純化す
ることが可能である。使用する酸性低級アルコール溶液
は生薬の種類により添加する酸量を変化させるが、一般
に低級アルコールに対し1%以下、好ましくは0.3〜
0.5%程度であり、低級アルコールはメタノール、エ
タノールが好ましい。抽出は加温。(Means and effects for solving the problem) As a result of examining the methods for collecting antitumor substances from iron tree leaves, somia grass, sawa lacquer, and konmugi, it was found that all of these herbal medicines contain strong antitumor substances. It is recognized that anti-tumor substances can be collected using the same collection method from iron tree leaves, Somia grass, and Sawa lacquer, but anti-tumor substances cannot be collected from Soumai using the above-mentioned three methods. Knew. Extract iron tree leaves, blue ear grass, and sawa lacquer with acidic lower alcohol, and remove the solvent to obtain the extract. This extracted extract was dissolved in a dilute alkaline aqueous solution, and
- After adding butanol and shaking, collect the butanol layer and add butanol to obtain the antitumor substance. This substance can be purified and purified by chromatography or other conventional methods. The amount of acid added to the acidic lower alcohol solution to be used varies depending on the type of herbal medicine, but it is generally 1% or less, preferably 0.3 to 0.3%, based on the lower alcohol.
The amount is about 0.5%, and the lower alcohol is preferably methanol or ethanol. Extraction is heated.
室温いずれでも可能である。アルカリ水溶液のアルカリ
濃度は1%以下、好ましくは0.1%程度である。This can be done at room temperature. The alkaline concentration of the alkaline aqueous solution is 1% or less, preferably about 0.1%.
瞿麦より抗腫瘍性物質を採取するには、瞿麦をまず低級
アルコールで処理し、アルコール抽出残を熱水で抽出し
、熱水抽出液を減圧下に水を情夫して抽出物をえ、この
抽出物を抗腫瘍性物質として使用する。要すれば更にこ
の抽出物を弱酸又は弱アルカリに溶解し、それをn−ブ
タノールで抽出し、ブタノール抽出物を採取する。この
操作によ・り更に採取物は純化される。又クロマトグラ
フィその他により純化することも可能である。In order to collect anti-tumor substances from the barley, the barley is first treated with lower alcohol, the alcohol extraction residue is extracted with hot water, and the hot water extract is mixed with water under reduced pressure to obtain an extract. The extract is used as an antitumor substance. If necessary, this extract is further dissolved in a weak acid or a weak alkali, and extracted with n-butanol to collect a butanol extract. This operation further purifies the sample. It is also possible to purify by chromatography or other methods.
このようにして得られた物質は安定で、以下に示すよう
に強い抗腫瘍活性を存し、単独又は他の薬物と混じて抗
癌剤として使用することができる。The substance thus obtained is stable and has strong antitumor activity as shown below, and can be used alone or in combination with other drugs as an anticancer agent.
使用した抽出法及び採取された物質の性質より考えて、
鉄樹葉、蒼耳草及び沢漆より得られた抗腫瘍性物質は含
窒素化合物、アルカロイドを、?R麦より得られたそれ
は、フェノール性化合物、或いは配糖体を主成分とする
と考えられ、これら採取物の抗腫瘍性はそのアルカロイ
ド、フェノール性或いは配糖体によるものと考えられる
。Considering the extraction method used and the nature of the material collected,
The anti-tumor substances obtained from iron tree leaves, blue ear grass and sawa lacquer contain nitrogen-containing compounds and alkaloids? It is thought that the substance obtained from R wheat contains phenolic compounds or glycosides as a main component, and the antitumor properties of these harvested products are thought to be due to their alkaloids, phenolic properties, or glycosides.
以下に実施例をあげて本発明を具体的に説明する。The present invention will be specifically explained below with reference to Examples.
例1゜
蒼耳草22.2gにメタノール0.2j2を加え、これ
に5−の濃塩酸を添加し、1時間還流下に加熱して抽出
する。この操作を2回繰り返して抽出液を合し、減圧下
に溶媒を留去して抽出エキスをえた。Example 1 0.2j2 of methanol was added to 22.2 g of Blue Ear Grass, 5-concentrated hydrochloric acid was added thereto, and the mixture was extracted by heating under reflux for 1 hour. This operation was repeated twice, the extracts were combined, and the solvent was distilled off under reduced pressure to obtain an extracted extract.
この抽出エキスを0.1%苛性ソーダ水溶液550 d
に溶解し、当量のn−ブタノールで3回抽出し、ブタノ
ール液を合して減圧下にブタノールを留去し、固体1.
17gをえた。This extracted extract was added to 550 d of 0.1% caustic soda aqueous solution.
The butanol solutions were combined and the butanol was distilled off under reduced pressure to obtain a solid 1.
I gained 17g.
この固体を紫外線吸収スペクトルで分析の結果、メタノ
ール中で218+wμに極大吸収をもち、320および
400mμにショルダーをもつ。Analysis of this solid by ultraviolet absorption spectrum revealed that it had a maximum absorption at 218+wμ in methanol, and shoulders at 320 and 400 mμ.
例2゜
鉄樹葉22.2gを蒼耳草の代りに使用した以外は、例
1.と同じ操作を行い、固体3.52gを得た。この固
体を紫外線吸収スペクトルで分析の結果、メタノール中
で228および282mμに極大吸収をもつ。Example 2゜Example 1 except that 22.2g of iron tree leaves were used in place of the blue ear grass. The same operation as above was performed to obtain 3.52 g of solid. As a result of ultraviolet absorption spectrum analysis of this solid, it has maximum absorption at 228 and 282 mμ in methanol.
例3゜
沢漆22.2gを蒼耳草の代りに使用した以外は、例1
.と同じ操作を行い、固体36.9gを得た。この固体
を紫外線吸収スペクトルで分析の結果、メタノール中2
15および400mμに極大吸収をもち、26抛μにシ
ョルダーをもつ。Example 3 Example 1 except that 22.2g of ゜Sawa urushi was used instead of Soumiso
.. The same operation as above was performed to obtain 36.9 g of solid. As a result of analyzing this solid by ultraviolet absorption spectrum, it was found that 2
It has maximum absorption at 15 and 400 mμ and a shoulder at 26 mμ.
例4゜
瞿麦24.4gにメタノール0.1!1M加えて1時間
還流下に加熱して抽出する。メタノールを濾過し、残生
薬に0.21!の水を加えて1時間加熱還流して抽出す
る。減圧下に溶媒を留去して固体1.08gを得た。こ
れの水溶液を紫外線吸収スペクトルで分析した結果、2
12.269および331mμに極大吸収をもつ。Example 4 0.1!1 M of methanol was added to 24.4 g of ゜mugi and extracted by heating under reflux for 1 hour. Methanol is filtered and residual medicine is 0.21! Add water and heat under reflux for 1 hour for extraction. The solvent was distilled off under reduced pressure to obtain 1.08 g of solid. As a result of analyzing this aqueous solution by ultraviolet absorption spectrum, 2
It has maximum absorption at 12.269 and 331 mμ.
例5゜
瞿麦4gを400rdの精製水に溶解し、稀塩酸でpH
に調整したあと、100−のn−ブタノールで4回抽出
し、ブタノール抽出液を合わせて減圧下に溶媒を留去し
て、活性物質786mgを得た。尚、水層には活性は認
められなかった。Example 5 Dissolve 4g of ゜mugi in 400rd purified water and adjust the pH with dilute hydrochloric acid.
The mixture was extracted with 100-n-butanol four times, and the butanol extracts were combined and the solvent was distilled off under reduced pressure to obtain 786 mg of the active substance. Note that no activity was observed in the aqueous layer.
例6゜
マウス白血病由来の培養株細胞(L−5178Y)に対
する試験管内での殺細胞作用。Example 6 In vitro cell killing effect on cultured cells (L-5178Y) derived from mouse leukemia.
本発明により採取された活性物質を生理食塩水に溶解し
、10%牛脂児血清を含むRP旧−1640培地中で継
代培養されている白血病細胞L−5178Y1、OX
10’個/ mlに添加して37℃で48時間5%炭酸
ガス培養器中で培養した後、対照群と試料添加群につい
てその生細胞をトリパンブルー染色によって検鏡してそ
れぞれの活性物質について50%阻止濃度枢動(IC5
゜)を求めた。その結果を表−1,に示す。The active substance collected according to the present invention is dissolved in physiological saline and leukemia cells L-5178Y1, OX are subcultured in RP old-1640 medium containing 10% tallow serum.
After adding 10' cells/ml and culturing in a 5% carbon dioxide incubator at 37°C for 48 hours, the living cells of the control group and the sample addition group were examined using trypan blue staining to determine the presence of each active substance. 50% inhibitory concentration pivot (IC5
゜) was calculated. The results are shown in Table 1.
表−1,試験管内におけるL−5178Yに対する殺腫
瘍細胞作用
蒼耳草
沢漆
鉄樹葉
瞿麦
例7゜
動物実験腫瘍P−388を用いる抗腫瘍試験雌のBDF
、マウスの腹腔内に、1週間1回継代されているP−
388の腹水癌細胞1.OX 106個/マウスを腹腔
内に移植し、移植後24時間より本発明の活性物質を腹
腔内に投与した。投与回数は1日1回5日間とし、その
生存日数を無処理群のそれと比較して、延命率を算出し
た。その結果を表−2に示す。Table 1. Tumoricidal cell effect on L-5178Y in vitro
, P-, which has been passaged intraperitoneally once a week in mice.
388 ascites cancer cells 1. 106 OX/mouse were implanted intraperitoneally, and the active substance of the present invention was intraperitoneally administered 24 hours after implantation. The frequency of administration was once a day for 5 days, and the survival rate was calculated by comparing the survival days with that of the untreated group. The results are shown in Table-2.
率を算出した。その結果を表−3,に示す。The rate was calculated. The results are shown in Table 3.
表−2,実験動物腫瘍P−388に対する抗腫瘍作用
試 料 投与量 延命率鉄樹葉 2
00mg/kg X 5回 11.1%蒼耳草
200// X5〃18.1%沢漆 200 //
X 5 // 10.2%讐瞿麦200 // X
5 // 20.1%表3.実験動物腫瘍ザルコマ
180に対する抗腫瘍作用
試料
投与量
延命率
蒼耳草
沢漆
鉄樹葉
瞿麦
100mg/kgx 5 、F
100mg/kg x 5 tt
100mg/kg X 5回
100mg/kgX 5 〃
例8゜
動物実験腫瘍ザルコマ(Sarcoma) 180を用
いる抗腫瘍試験Table 2, Antitumor activity against experimental animal tumor P-388 Sample Dose Life extension rate Iron tree leaf 2
00mg/kg x 5 times 11.1% Soumiagusa
200 // X5〃18.1% Sawa lacquer 200 //
X 5 // 10.2% barley 200 // X
5 // 20.1%Table 3. Antitumor effect on experimental animal tumor Sarcoma 180 Sample dose prolongation survival rate Soomi Kusazawa Lacquer Iron Tree Leaves 100mg/kg x 5, F 100mg/kg x 5 tt 100mg/kg x 5 times 100mg/kg x 5 〃 Example 8゜Animal experiment Antitumor test using Sarcoma 180
Claims (2)
質をアルカリ水溶液に溶かし、該アルカリ水溶液をブタ
ノールで抽出し、ブタノール抽出物を採取することを特
徴とする抗腫瘍性物質の採取法。(1) A method for collecting an anti-tumor substance characterized by dissolving an acidic alcohol extracted substance of iron tree leaves, blue ear grass, or sawa lacquer in an alkaline aqueous solution, extracting the alkaline aqueous solution with butanol, and collecting a butanol extract. .
取することを特徴とする抗腫瘍性物質の採集法。(2) A method for collecting an anti-tumor substance, which comprises collecting a hot water extract of the residue of lower alcohol extraction of porgy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1099949A JPH0253730A (en) | 1989-04-21 | 1989-04-21 | Collection of antitumor substance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1099949A JPH0253730A (en) | 1989-04-21 | 1989-04-21 | Collection of antitumor substance |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63200100A Division JPH0249730A (en) | 1988-08-12 | 1988-08-12 | Method for extracting antitumor substance |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0253730A true JPH0253730A (en) | 1990-02-22 |
Family
ID=14260956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1099949A Pending JPH0253730A (en) | 1989-04-21 | 1989-04-21 | Collection of antitumor substance |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0253730A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100378904B1 (en) * | 1998-04-23 | 2003-08-21 | 주식회사 엘지생명과학 | Extraction of growth hormone releasing factor from natural medicinal plants and water-soluble phlomidis radix extract |
US7008650B2 (en) * | 2001-08-09 | 2006-03-07 | Lam Paul Y S | Compositions for the treatment of acquired immunodeficiency disease |
-
1989
- 1989-04-21 JP JP1099949A patent/JPH0253730A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100378904B1 (en) * | 1998-04-23 | 2003-08-21 | 주식회사 엘지생명과학 | Extraction of growth hormone releasing factor from natural medicinal plants and water-soluble phlomidis radix extract |
US7008650B2 (en) * | 2001-08-09 | 2006-03-07 | Lam Paul Y S | Compositions for the treatment of acquired immunodeficiency disease |
US7364760B2 (en) | 2001-08-09 | 2008-04-29 | Chinese Herbal Usa Inc. | Compositions for the treatment of acquired immunodeficiency disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4440767B2 (en) | Herbal molecules as potential anti-leukemic agents | |
JP2014111664A (en) | Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning/memory disorders, movement disorders and the like, and pharmaceutical agent and food comprising the same | |
JP2016539184A (en) | Algal extract for use as an immunomodulator | |
CN1307131C (en) | Antineoplastic extract of Chinese fan palm and its preparation method and uses | |
CN103222988A (en) | Periplaneta americana extract and its preparation method and use | |
Nair et al. | Antitumour principles from Ixora javanica | |
CN114588184B (en) | Herba Saururi extract, and preparation method and application thereof | |
CN109674866A (en) | A kind of anti-human primary gastrointestinal cancers pharmaceutical composition, preparation method and applications | |
CN102319319A (en) | Solanum lyratum extract, and anticancer medicine comprising solanum lyratum extract | |
US20040241184A1 (en) | Fermentation product of cyptoporous volvatus and its preparation method and use | |
US3136693A (en) | Therapeutic compositions and process for obtaining the same | |
CN101396373B (en) | Cinobufacini extract and preparation method thereof | |
JPH0253730A (en) | Collection of antitumor substance | |
JP2007039421A (en) | Skin care preparation for ameliorating roughened skin | |
JP4480204B2 (en) | Anti-tumor fraction of Kawariharatake | |
CN107213176B (en) | Hydrangea macrophylla leaf extract, and pharmaceutical composition, preparation method and application thereof | |
KR20040047617A (en) | The mixtures for nicotine elimination and their manufacturing method | |
DE19600301C2 (en) | Macrocyclic compounds built up by cyclooligomerization of the simple carbon suboxide C¶3¶O¶2¶, processes for their production and recovery and their use | |
CN109294984A (en) | A kind of Lentinan and preparation method thereof of internal efficient amplification NK cell | |
KR100200182B1 (en) | Composition having liver-protecting effect, which contains isoflavone isolated from astragalus membranaceus | |
CN108042600A (en) | The application of Cortex Eucommiae lignanoid and eucommia ulmoides extracts in Hsp90 alpha inhibitors and antitumor drug is prepared | |
CN115531413A (en) | Medicine for targeted therapy of thyroid cancer and preparation method thereof | |
JP6969041B2 (en) | Vascular Endothelial Nitric Oxide Synthetic Enzyme Production Promoter and Oral Composition | |
CN107865927A (en) | A kind of clarification process and method of quality control of the pharmaceutical composition that there are treatment livid ring around eye to act on | |
SHIVANAND | PHARMACOGNOSTICAL, PHYTOCHEMICAL AND ANTICANCER ACTIVITY OF THE LEAVES OF ASPARAGUS RACEMOSUS WILLD.,(LILIACEAE) |